The complete data for Phase I and II, and partial data for Phase III trials of Covaxin have been thoroughly scrutinised by the regulators in India, Bharat Biotech said in a statement.from Top Business News- News18.com https://ift.tt/3iBKwCr
via IFTTT
No comments:
Post a Comment